Wells Fargo downgrades Ovintiv to Equal Weight, lowers price target to $40

As previously reported, Wells Fargo analyst Roger Read downgraded Ovintiv to Equal Weight from Overweight with a price target of $40, down from $64. The firm cites deteriorating capital efficiency trends, pending A&D transactions and its updated commodity price deck.